Searching for 1 ml Wegovy? Here's what the volume figure actually tells you

The myth: '1 ml Wegovy' is a dose you can track or compare

A question our prescribers hear most weeks is some version of: 'I've seen Wegovy described in millilitres, is that what I should be looking for on the pen?' It's a reasonable thing to wonder, especially if you've spotted listings or descriptions online that quote volume rather than weight. The misconception is understandable, but it matters to correct it.

Wegovy's active doses (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg, and now 7.2 mg) are all expressed in milligrams of semaglutide. The volume of solution the pen injects is a pharmaceutical engineering detail: manufacturers calibrate it so the right concentration is delivered in a consistent, manageable subcutaneous injection. That volume doesn't change meaningfully from dose level to dose level, and it is never something a patient adjusts or dials up. If someone is quoting millilitres as if they're a therapeutic marker, that's a sign the information hasn't come from a licensed clinical source.

This distinction matters for safety too. Counterfeit or unregulated products have been described and sold using volume-based language precisely because it sounds clinical without conforming to the licensed product's actual specifications. The MHRA's Yellow Card scheme allows anyone to report a suspected fake pen, and the MHRA has warned publicly that products sold without a legitimate prescription route have, in documented cases, contained completely different substances.

What the Wegovy pen actually delivers, and how the real titration schedule works

The licensed Wegovy injection pen used in the UK is a pre-filled, pre-set device. You do not load it, draw it up, or select a volume. Each pen contains the dose your prescriber has specified, and the injection mechanism delivers it subcutaneously in one press. The titration schedule (starting at 0.25 mg, stepping up through 0.5 mg, 1.0 mg and 1.7 mg, reaching the standard 2.4 mg maintenance dose) is determined by your prescriber based on how you're tolerating treatment, not by anything you measure yourself.

In January 2026, the MHRA also approved a 7.2 mg maintenance dose. A dedicated single-dose 7.2 mg pen (one pre-set weekly injection with a built-in covered needle that locks after use) received MHRA approval on 14 April 2026, offering a higher ceiling for adults with a BMI of 30 or above. As the gov.uk announcement confirmed, titration still starts at 0.25 mg; the 7.2 mg dose is the maximum, reached only after the full escalation pathway under prescriber guidance.

The takeaway: when you read about Wegovy, look for the milligram figure. That's the clinically meaningful number. Volume language, by contrast, belongs to the manufacturing specification, not to the conversation between you and your prescriber.

Who Wegovy is licensed for, and what the assessment looks at beyond BMI

Wegovy holds a UK licence for weight management in adults with a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or prediabetes. Lower BMI thresholds apply for some ethnic backgrounds under current UK clinical guidance. Those figures are a starting point for eligibility, not a guarantee of approval, the prescriber's assessment covers your full medical history, current medicines, any contraindications and whether the treatment makes clinical sense for you right now.

For context on the evidence behind Wegovy, the STEP 1 trial published in the New England Journal of Medicine found an average weight reduction of around 15% over 68 weeks at the 2.4 mg dose, alongside lifestyle changes. Those results come from a specific clinical context: structured support, titrated dosing, regular review. Replicating that context is exactly what a proper prescription pathway provides. You can read more about how semaglutide works and explore the full Wegovy overview to understand what the treatment involves day to day.

If you're curious about how the different Wegovy dose levels compare in terms of what the pen delivers, the Wegovy ml guide covers the volume question in more detail. And if you've been comparing semaglutide formulations, our 3 ml semaglutide page addresses similar questions about how that particular injectable format is measured and described alongside the 1 ml semaglutide page, which covers the same ground for the smaller volume.

How to access Wegovy through a regulated UK route

Wegovy is a prescription-only medicine. The only lawful route to obtaining it in the UK is via a prescription issued by a qualified prescriber following a clinical assessment. That assessment cannot be skipped, shortened to a checkbox or replaced by a volume calculation.

Online pharmacies offering these medicines are required to be registered with the GPhC, you can check any provider at the GPhC register before sharing any personal or medical information. Sellers quoting millilitre volumes as dose guidance, or offering pens without a proper clinical process, are a red flag worth taking seriously.

If you want to understand the cost of Wegovy through a private prescription, that page covers what a legitimate price typically includes and why the cheapest listing answers the wrong question. For a broader look at weight-loss treatment options, the weight-loss overview sets out what's currently licensed in the UK and how different treatments compare. When you're ready to find out whether Wegovy is clinically suitable for you, start your free consultation with our prescribers, every application is read by a real clinician, not automated software.